XML 95 R67.htm IDEA: XBRL DOCUMENT
v3.25.0.1

INCENTIVE STOCK PLANS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Incentive Compensation Costs | A summary of our stock-based incentive compensation cost is presented below:
| 2024 |  | 2023 |  | 2022
Selling and general expenses | $12,778 |  |  | $12,710 |  |  | $10,767 |
Cost of sales | 1,122 |  |  | 986 |  |  | 1,226 |
Timber and Timberlands, net (a) | 332 |  |  | 306 |  |  | 363 |
Total stock-based incentive compensation | $14,232 |  |  | $14,002 |  |  | $12,356 |
Tax benefit recognized related to stock-based incentive compensation expense (b) | $695 |  |  | $677 |  |  | $603 |
(a)Represents amounts capitalized as part of the overhead allocation of timber-related costs. (b)A valuation allowance is recorded against the tax benefit recognized as we do not expect to be able to realize the benefit in the future.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | A summary of our restricted stock units is presented below:
| 2024 |  | 2023 |  | 2022
Restricted stock units granted | 212,415 |  |  | 207,006 |  |  | 130,213 |
Weighted average price of restricted stock units granted | $32.46 |  |  | $32.93 |  |  | $41.81 |
Intrinsic value of restricted stock units outstanding (a) | $12,673 |  |  | $16,068 |  |  | $13,826 |
Grant date fair value of restricted stock units vested | 5,949 |  |  | 4,454 |  |  | 2,475 |
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on restricted stock units vested | 2,186 |  |  | 1,665 |  |  | 1,063 |
(a)Intrinsic value of restricted stock units outstanding is based on the market price of the Company’s stock at December 31, 2024, 2023 and 2022.
| 2024
| Number of Shares |  | Weighted Average Grant Date Fair Value
Non-vested Restricted Stock Units at January 1, | 480,925 |  |  | $32.74 |
Granted | 212,415 |  |  | 32.46 |
Vested | (189,934) |  |  | 31.32 |
Cancelled | (17,854) |  |  | 32.63 |
Non-vested Restricted Stock Units at December 31, | 485,552 |  |  | $33.17 |
A summary of our restricted stock is presented below:
| 2024 |  | 2023 |  | 2022
Restricted stock granted | 32,928 |  |  | 36,403 |  |  | 22,800 |
Weighted average price of restricted stock granted | $30.37 |  |  | $30.22 |  |  | $38.60 |
Intrinsic value of restricted stock outstanding (a) | — |  |  | $66 |  |  | $620 |
Grant date fair value of restricted stock vested | 1,047 |  |  | 1,647 |  |  | 2,478 |
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on restricted shares vested | 20 |  |  | 208 |  |  | 708 |
(a)Intrinsic value of restricted stock outstanding is based on the market price of the Company’s stock at December 31, 2023 and 2022.
| 2024
| Number of Shares |  | Weighted Average Grant Date Fair Value
Non-vested Restricted Stock at January 1, | 1,973 |  |  | $24.01 |
Granted | 32,928 |  |  | 30.37 |
Vested | (34,901) |  |  | 30.01 |
Non-vested Restricted Stock at December 31, | — |  |  | — |
Schedule of Nonvested Performance-based Units Activity | A summary of our performance share units is presented below:
| 2024 |  | 2023 |  | 2022
Common shares reserved for performance shares granted during year | 320,640 |  |  | 285,863 |  |  | 193,333 |
Weighted average fair value of performance share units granted | $34.51 |  |  | $37.77 |  |  | $45.68 |
Intrinsic value of outstanding performance share units (a) | $11,463 |  |  | $12,730 |  |  | $13,123 |
Fair value of performance shares vested | 6,388 |  |  | 5,863 |  |  | 5,549 |
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on performance shares vested | 1,975 |  |  | 2,342 |  |  | 2,454 |
(a)Intrinsic value of outstanding performance share units is based on the market price of the Company's stock at December 31, 2024, 2023 and 2022.
| 2024
| Number of Units |  | Weighted Average Grant Date Fair Value
Outstanding Performance Share units at January 1, | 381,034 |  |  | $39.56 |
Granted | 183,223 |  |  | 34.51 |
Units Distributed | (108,217) |  |  | 36.08 |
Other Cancellations/Adjustments | (16,854) |  |  | 34.76 |
Outstanding Performance Share units at December 31, | 439,186 |  |  | $38.50 |
Expected volatility was estimated using daily returns on the Company’s common shares for the three-year period ending on the grant date. The risk-free rate was based on the 3-year U.S. Treasury rate on the date of the award. The dividend yield was not used to calculate fair value as awards granted receive dividend equivalents. Grants made to Vice Presidents and above are subject to a one-year post-vest holding period and include an additional discount for liquidity. The following table provides an overview of the assumptions used in calculating the fair value of the awards granted for the three years ended December 31:
| 2024 |  | 2023 |  | 2022
Expected volatility | 26.4 | % |  | 29.9 | % |  | 38.1 | %
Risk-free rate | 4.5 | % |  | 3.7 | % |  | 2.6 | %
Liquidity discount applied to grants with a post-vesting holding restriction | 3.9 | % |  | 4.7 | % |  | 4.2 | %
Schedule of Share-based Compensation, Stock Options, Activity | A summary of the status of our stock options as of and for the year ended December 31, 2024 is presented below:
| 2024
| Number of Shares |  | Weighted Average Exercise Price (per common share) |  | Weighted Average Remaining Contractual Term (in years) |  | Aggregate Intrinsic Value
Options outstanding at January 1, | 24,724 |  |  | $31.83 |  |  |  |  |
Exercised | — |  |  | — |  |  |  |  |
Cancelled or expired | (24,724) |  |  | 31.83 |  |  |  |  |
Options outstanding at December 31, | — |  |  | — |  |  | — |  |  | — |
Options exercisable at December 31, | — |  |  | — |  |  | — |  |  | — |
A summary of additional information pertaining to our stock options is presented below:
| 2024 |  | 2023 |  | 2022
Intrinsic value of options exercised (a) | — |  |  | $2 |  |  | $300 |
Cash received from exercise of options | — |  |  | 75 |  |  | 2,466 |
(a)Intrinsic value of options exercised is the amount by which the fair value of the stock on the exercise date exceeded the exercise price of the option.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration